HYDERABAD: Intestinal ultrasound has the lowest carbon footprint and hospital cost among the imaging tests assessed for monitoring inflammatory bowel disease (IBD), according to a study by AIG Hospitals. The findings suggest that the procedure could be used more widely for follow-up care where clinically appropriate.The EVERGREEN-IBD study, published in Alimentary Pharmacology & Therapeutics, compared the environmental impact and costs of laboratory tests, colonoscopy, CT, MRI and intestinal ultrasound.Conducted at AIG Hospitals in December 2025, the study found that intestinal ultrasound generated 0.85 kg of carbon dioxide equivalent per procedure, compared with 3.87 kg for colonoscopy/enteroscopy, 5.82 kg for CT and 21.25 kg for MRI. Its carbon footprint was nearly 96% lower than that of MRI.The hospital cost of intestinal ultrasound was also about half that of colonoscopy and one-sixth that of MR enterography.IBD, which includes Crohn’s disease and ulcerative colitis, often requires repeated investigations over a patient’s lifetime. Intestinal ultrasound uses a probe placed over the abdomen to assess bowel inflammation without radiation, sedation or bowel preparation.Dr D Nageshwar Reddy, chairperson of AIG Hospitals, said healthcare must balance clinical excellence, affordability and environmental responsibility, particularly when treating chronic conditions that require long-term care.Dr Rughwani said the findings highlighted the need to expand access to intestinal ultrasound and use it more consistently for suitable follow-up assessments.However, the researchers clarified that ultrasound cannot replace colonoscopy, CT or MRI in all situations. Colonoscopy remains essential for diagnosis and cancer surveillance, while CT and MRI are important for assessing the extent of the disease and identifying complications.
